S. Agkatsev

RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo

K. Channon, R. Wade-Martins, L. Seymour, 2011, Gene Therapy.

First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma

W. Stummer, E. Hattingen, M. Stuschke, 2022, Neuro-oncology advances.

A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein Receptor

G. Wynne, G. Douglas, A. Hale, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Regulation of MITF and Brn2 in melanoma

S. Agkatsev, S. Agkatsev, 2014 .

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma

U. Sure, K. Keyvani, C. Kleinschnitz, 2023, Neuro-oncology advances.